Business
Johnson & Johnson in talks to acquire eye disease biotech for up to $3.4bn
Johnson & Johnson is exploring the purchase of a biotechnology firm specializing in eye diseases in a deal valued at up to…
Johnson & Johnson is exploring the purchase of a biotechnology firm specializing in eye diseases in a deal valued at up to…